ERRATA

The October 10, 2013, article by Elisei et al, entitled “Cabozantinib in Progressive Medullary Thyroid Cancer” (J Clin Oncol 31:3639–3646, 2013), contained an error.

In Figure 2B, the labels for subgroups with Negative and Unknown M918T mutational status among patients with sporadic disease were inadvertently transposed. The corrected figure is reprinted below in its entirety.

The online version has been corrected in departure from the print. The authors apologize for the mistake.